The effect of anastrozole on bone mineral density during the first 5 years of adjuvant treatment in postmenopausal women with early breast cancer

PURPOSE: The administration of aromatase inhibitors is associated with bone loss in postmenopausal women. We assessed changes in bone mineral density (BMD) from baseline to 60 months of treatment in patients receiving anastrozole as initial adjuvant therapy. METHODS: Postmenopausal women with hormon...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Hiroaki, Hirano, Akira, Ogura, Kaoru, Hattori, Akinori, Kamimura, Mari, Okubo, Fumie, Tagawa, Hiroko, Sakaguchi, Shiho, Kinoshita, Jun, Shimizu, Tadao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486652/
https://www.ncbi.nlm.nih.gov/pubmed/26155442
http://dx.doi.org/10.1186/s40064-015-1096-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486652/
https://www.ncbi.nlm.nih.gov/pubmed/26155442
http://dx.doi.org/10.1186/s40064-015-1096-2

Ejemplares similares